Profile

    Corporate information

    Official name
    Apeiron Investment Group Ltd

    Registration country
    Investment activity status
    Active investor

    Company type

    The family office and merchant banking business of Christian Angermayer.

    Overview
    Apeiron Investment Group Ltd, Malta, is the family office and merchant banking business of Christian Angermayer. Apeiron focuses on Financial Services (especially fintech and crypto assets), Deep-Tech (AI, space-tech, cybersecurity etc.), Life Sciences, Media & Entertainment and Real Estate & Prop-Tech. In general, we invest in all phases and stages of a company’s life cycle, but our focus lies on non-listed Seed/Start-up investments and larger size Restructuring & Special Situations deals (often listed). We have a special passion for blockchain and crypto companies. All our investments in this space are done via our subsidiary CRYPTOLOGY Asset Group PLC. In our life sciences practice, we aim to find solutions to help people live longer, healthier and happier lives: With ATAI Life Sciences, we are developing psychedelic substances to address significant unmet medical needs that are rooted in a lack of innovation in Neuropsychiatry over the last decades. With REJUVERON we focus on cutting-edge technologies with the potential to significantly prolong human life span. With Presight Capital, we invest in early stage rounds primarily in the US. In order to complement and diversify our portfolio, which has a bias towards Europe, we invest in Hedge Funds and Venture Capital Funds globally – with a focus on funds investing in the US and China/Asia. With Apeiron Advisory Ltd., we advise international investors on their investments especially in Germany and Africa.

    Selected investments

    Country Date Notes
    Isar Aerospace Technologies GmbH
    Developer and manufactures launch vehicles and full-featured propulsion systems for suborbital and orbital launcher.
    Germany 9 Dec 2020 Series B
    Initial investment. Round participant. Active
    Juvenescence Ltd
    Technologies based on Artificial Intelligence in the fields of life extension and the prevention of age-related diseases.
    United Kingdom 8 Jan 2018 Seed
    Round participant. Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.